Skip to the page

Data / Form D filings / Circle Pharma, Inc.

Circle Pharma, Inc.: Form D filings

Circle Pharma, Inc., a company in South San Francisco, CA, filed 7 Form D notices with the SEC between 2016 and 2025. The latest, on January 10, 2025, reports $92.4 million sold of a $117.4 million offering to 14 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
681 GATEWAY BLVD, 3RD FLOOR, South San Francisco, CA, 94080
Phone
(650) 392-0350
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1684286

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 10, 2025Amendment$117,374,782$92,444,167$24,930,61514Jun 28, 2024sec.gov
Aug 29, 2024Amendment$117,374,782$63,171,998$54,202,78414Jun 28, 2024sec.gov
Jul 3, 2024New notice$117,374,782$54,171,999$63,202,78312Jun 28, 2024sec.gov
Mar 22, 2022Amendment$66,304,990$66,304,99020Jun 15, 2021sec.gov
Jun 29, 2021New notice$66,304,990$35,652,490$30,652,50019Jun 15, 2021sec.gov
Mar 23, 2020New notice$45,000,000$14,999,999$30,000,0017Mar 16, 2020sec.gov
Sep 9, 2016New notice$6,047,554$3,808,348$2,239,2064Sep 6, 2016sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Thilo H. SchroederDirector
Stephen H. KelseyDirector
David J. EarpExecutive Officer, Director
Matthew P. JacobsonDirector
Walter H. MoosDirector
Paul H. ParkExecutive Officer
James H. EvangelistaDirector
John JoseyDirector

Other companies in California that filed recently

Every Form D from the week of Jan 6, 2025 · All recent filings in California · All recent Other filings

Read from SEC EDGAR. Amount sold is what Circle Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.